Results 131 to 136 of about 3,209 (136)
Some of the next articles are maybe not open access.
Cancer Research, 2016
Abstract In recent years, understanding of tumor immunology has led to significant advances in cancer immunotherapy. New approaches include selective blockade of checkpoints, harnessing tumor infiltrating lymphocytes (TILs) and use of intratumoral oncolytic viruses.
Daqing Wang +5 more
openaire +1 more source
Abstract In recent years, understanding of tumor immunology has led to significant advances in cancer immunotherapy. New approaches include selective blockade of checkpoints, harnessing tumor infiltrating lymphocytes (TILs) and use of intratumoral oncolytic viruses.
Daqing Wang +5 more
openaire +1 more source
Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences, 2014
To explore the role of indoleamine-pyrrole 2,3-dioxygenase (IDO), an immunomodulatory enzyme, in renal cell carcinoma (RCC).A total of 40 patients diagnosed as RCC in the Second Xiangya Hospital were included in this study. All patients received nephrectomy. The histopathological features of samples were assessed semi-quantitatively.
Fang, Yuan +3 more
openaire +1 more source
To explore the role of indoleamine-pyrrole 2,3-dioxygenase (IDO), an immunomodulatory enzyme, in renal cell carcinoma (RCC).A total of 40 patients diagnosed as RCC in the Second Xiangya Hospital were included in this study. All patients received nephrectomy. The histopathological features of samples were assessed semi-quantitatively.
Fang, Yuan +3 more
openaire +1 more source
Indoleamine-pyrrole 2,3 dioxygenase (IDO1; INDO; IDO)
Science-Business eXchange, 2010openaire +1 more source
Indoleamine 2,3-dioxygenase or Indoleamine-pyrrole 2,3-dioxygenase (IDO or INDO EC 1.13.11.42)
2009openaire +1 more source